Pfizer Forecasts $15 Billion In Revenue From COVID Vaccine In 2021

(Video length 00:01:13)

CNBC's Meg Tirrell breaks down Pfizer's fourth-quarter earnings results and adjusted full-year guidance.

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.